Publications by authors named "Deborah A Todhunter"

Claim this Profile
A
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.
Philippa R Kennedy, Daniel A Vallera, Brianna Ettestad, Caroline Hallstrom, Behiye Kodal, Deborah A Todhunter

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.
Michelle K Gleason, Michael R Verneris, Deborah A Todhunter, Bin Zhang, Valarie McCullar

Mol Cancer Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model.
Seunguk Oh, Deborah A Todhunter, Angela Panoskaltsis-Mortari, Donald J Buchsbaum, Shoko Toma

Pancreas· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.
Seunguk Oh, John R Ohlfest, Deborah A Todhunter, Vincent D Vallera, Walter A Hall

J Neurooncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice.
Edward Rustamzadeh, Walter A Hall, Deborah A Todhunter, Vincent D Vallera, Walter C Low

Int J Cancer· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.
Edward Rustamzadeh, Daniel A Vallera, Deborah A Todhunter, Walter C Low, Angela Panoskaltsis-Mortari

J Neurooncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice.
Edward Rustamzadeh, Walter A Hall, Deborah A Todhunter, Walter C Low, Haiying Liu

Int J Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
Daniel A Vallera, Deborah A Todhunter, David W Kuroki, Yanqun Shu, Andy Sicheneder

Clin Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Deborah A Todhunter, Walter A Hall, Edward Rustamzadeh, Yanqun Shu, Sekou O Doumbia

Protein Eng Des Sel· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice.
Chunbin Li, Walter A Hall, Ni Jin, Deborah A Todhunter, Angela Panoskaltsis-Mortari

Protein Eng· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis